Silvie Ostřížková

Ms. Silvie Ostřížková

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
PRPetra Riedlova
Petra Riedlova
DKDagmar Kramna
Dagmar Kramna
SOSilvie Ostřížková
Silvie Ostřížková
HTHana Tomaskova
Hana Tomaskova
VJVitezslav Jirik
Vitezslav Jirik
Background: Thrombophilic mutations in genes for factor V Leiden and factor II prothrombin are among the most important risk factors for developing the thromboembolic disease (TED), along with the use of oral contraceptives (OCs) or smoking. Aim: This study aimed to investigate the occurrence of risk factors in young women using droplet digital PCR (ddPCR) and, based on the results of this investigation, to perform a cost–benefit analysis of ddPCR-based screening in young women starting to take OCs compared to the treatment costs of patients who develop preventable TED in the Czech Republic. Methods: In this cross-sectional study, female university students filled in a questionnaire and provided a blood sample for DNA isolation and ddPCR analysis of both aforementioned genetic risk factors. The results, along with data from literature and web search, were used for cost–benefit analysis valid for the Czech Republic. Results: Out of 148 participants, 30 (20%) were smokers and 49 (33%) took OCs. A mutation was confirmed in 6 women (4.1%) in the factor V gene and in 3 women (2%) in the factor II gene, respectively. A model calculation on a cohort of 50,000 women starting to use contraceptives in the Czech Republic every year showed that at maximum compliance, (i.e., non-use of OC and smoking cessation), screening could prevent 68 cases of TED over the course of the mean period of OC use (5.7 years). Economically, the costs of testing in this cohort (2.25 mil. USD) would be significantly lower than prevented treatment costs (16 mil. USD at maximum compliance); the cost–benefit break-even point would be at 14.1% compliance. Conclusion: The cost–benefit analysis based on our results indicates that screening for factor V Leiden and factor II prothrombin in young women before starting to use OCs would, in the conditions of the Czech Republic, likely be highly economically effective.

1 August 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
PRPetra Riedlova
Petra Riedlova
STSpiros Tavandzis
Spiros Tavandzis
JKJosef Kana
Josef Kana
SOSilvie Ostřížková
Silvie Ostřížková
DKDagmar Kramna
Dagmar Kramna
JRJaromir Roubec
Jaromir Roubec
Background: Lung carcinoma is one of the most common malignancies worldwide. At present, unfortunately, there are no markers that would allow early identification of this tumor in the preclinical or early clinical stage. The use of sniffer dogs has been reported to show some promise in early diagnosis of this type of cancer Aim: This study aimed to evaluate the possibility of utilizing changes in the heart rate of sniffer dogs (which increases when finding a positive sample) in tumor detection. Methods: This double-blinded pilot study included two sniffer dogs. A chest strap was fastened on the dog’s chests for heart rate monitoring while they were examining samples and heart rate was recorded. Test parameters (sensitivity, specificity, positive and negative predictive values) were then calculated, evaluating performances based on (i) the dog’s indications according to their training and (ii) the changes in their heart rates. Results: Calculation according to the dog’s indications revealed an overall sensitivity of 95.2% accompanied by a specificity of 81.8%, a PPV of 93.7%, and an NPV of 85.7%, respectively. These results were not significantly different from those evaluated by heart rate; heart rate monitoring was, however, burdened with a relatively high proportion of invalid experiments in which heart rate measurement failed. When the method of calculation was changed from rounds to individual samples, the test parameters further increased. Conclusions: This pilot study confirmed the hypothesis that heart rate increases in trained sniffer dogs when encountering samples from tumor-positive patients but remains unchanged when only negative samples are present. The reliability of results based on heart rate increase is similar to that obtained by a dog’s indications and, if the limitation represented by technical issues is overcome, it could serve as a valuable verification method.

14 November 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
SOSilvie Ostřížková
Silvie Ostřížková
JMJan Martinek
Jan Martinek
DBDenisa Budirská
Denisa Budirská
Hana ZelenáHana Zelená
Hana Zelená
AKAlena Kloudová
Alena Kloudová
HTHana Tomaskova
Hana Tomaskova
Background/Objectives: Following the global spread of SARS-CoV-2, there was an urgent need for vaccine development to support immune protection. This study aimed to evaluate the impact of active and hybrid immunity on the durability of immunoglobulin G (IgG), neutralizing antibodies, and cellular immune responses over a two-year period. Methods: This longitudinal study was conducted from February 2021 to December 2023 at the Public Health Institute in Ostrava, Czech Republic. Anti-S IgG was measured using ELISA (Euroimmun), neutralizing antibodies via an in-house virus neustralization test (VNT), and cellular immune response using the IGRA test (ELISA, Euroimmun). Participants also completed a questionnaire on demographics, COVID-19 history, symptoms, and vaccination. Statistical analysis included descriptive and non-parametric tests (Mann–Whitney U, Kruskal–Wallis) at a 5% significance level. Results: The cohort included 149 individuals, 97.3% of whom were vaccinated with Comirnaty (Pfizer/BioNTech). A total of 17% had confirmed infection prior to vaccination and showed up to two-fold higher neutralizing antibody levels (p < 0.001) within 2–6 weeks postvaccination. Postvaccination infection was reported in 35% of participants. Although antibody levels declined over the 2–100 week period, participants remained seropositive across all three parameters. Cellular immune response (interferon-γ) remained consistently high throughout follow-up. Conclusions: The study demonstrates long-term durability of IgG and neutralizing antibodies and confirms durable cellular immunity up to two years postvaccination. Hybrid immunity significantly enhanced neutralizing antibody levels, supporting its added value in protective immunity against SARS-CoV-2.

20 May 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
PRPetra Riedlova
Petra Riedlova
DKDagmar Kramna
Dagmar Kramna
SOSilvie Ostřížková
Silvie Ostřížková
HTHana Tomaskova
Hana Tomaskova
VJVitezslav Jirik
Vitezslav Jirik
Background: The noninvasive collection of saliva samples for DNA analyses is simple, and its potential for research and diagnostic purposes is great. However, DNA isolates from such samples are often of inferior quality to those from blood. Aim: The aim of this study was to investigate the robustness and sensitivity of the ddPCR instrument for genetic analyses from saliva samples of poor quality by comparing their results to those obtained using an established method from blood samples. Methods: Blood and saliva were collected from 47 university students, which was followed by manual isolation of DNA and analysis on droplet digital PCR (ddPCR). Results of analyses were supplemented with values of fractional abundances. Results: ddPCR proved to be highly suitable for analysis of even low-quality saliva samples (concentrations as low as 0.79 ng/µL), especially when augmented by fractional abundance data. This combination yielded 100% agreement with results obtained from blood samples. Conclusion: This study verified the applicability of ddPCR as a sensitive and robust method of genetic diagnostic testing even from low-quality saliva isolates. This makes it potentially suitable for a wide range of applications and facilitates the performance of large epidemiological studies, even if sampling or sample processing is suboptimal.

8 December 2022 in Czech Urology
Verified
Journal Article
Open access
PDF file
SOSilvie Ostřížková
Silvie Ostřížková
RZRenata Zlotkowska
Renata Zlotkowska
Ost???kov? S, Zlotkowska R. Vliv onemocn?n? covid-19 na mu?skou plodnost. Onemocn?n? covid-19 se od roku 2019 rychle roz???ilo nap??? kontinenty a zp?sobilo pandemii. ?ast?j?? v?skyt tohoto onemocn?n? byl pozorov?n u mu??, ??ste?n? vlivem vy??...